Labcorp (NYSE: LH) has reported strong financial results for the fourth quarter and full year 2025, showing revenue growth and improved earnings driven by its diagnostics operations. The company also provided optimistic guidance for full-year 2026, projecting continued revenue and adjusted EPS growth. Key initiatives included strategic acquisitions, significant investments in new facilities, and the launch of over 130 new tests.
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
Earnings Summary – Labcorp Reports Fourth Quarter and Full Year 2025 Results and Issues 2026 Guidance
Labcorp (NYSE: LH) has reported strong financial results for the fourth quarter and full year 2025, showing revenue growth and improved earnings driven by its diagnostics operations. The company also provided optimistic guidance for full-year 2026, projecting continued revenue and adjusted EPS growth. Key initiatives included strategic acquisitions, significant investments in new facilities, and the launch of over 130 new tests.